首页>
外国专利>
PHARMACEUTICAL COMPOSITION FOR INTEGRATED TREATMENT OF OCULAR SURFACE DISEASES IN PATIENTS SUFFERING PRIMARY OPEN-ANGLE GLAUCOMA
PHARMACEUTICAL COMPOSITION FOR INTEGRATED TREATMENT OF OCULAR SURFACE DISEASES IN PATIENTS SUFFERING PRIMARY OPEN-ANGLE GLAUCOMA
展开▼
机译：药物组合物治疗原发性开角型青光眼患者的眼表疾病
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine.;SUBSTANCE: invention refers to pharmacology and represents a pharmaceutical composition for integrated treatment of ocular surface diseases in the patients suffering primary open-angle glaucoma, on the basis of phospholipids and sulphated glycosaminoglycans, differing by the fact that composition represents a liposomal emulsion formed by phospholipids in the form of liposomes, of average particle size 0.05-0.22 mcm, and sulphated glycosaminoglycans with sulphated glycosaminoglycans presented by keratan sulphate sodium salt and chondroitin sulphate sodium salt with the ingredients of the composition taken in certain proportions, wt %.;EFFECT: invention provides preventing lachrymal production from decreasing, reducing tear evaporation, as well as avoiding pathological changes in conjunctival and corneal epithelial cells.;5 ex
展开▼
